首页> 外文期刊>Chemico-biological interactions >Inhalation toxicity of soman vapor in non-anesthetized rats: A preliminary assessment of inhaled bronchodilator or steroid therapy
【24h】

Inhalation toxicity of soman vapor in non-anesthetized rats: A preliminary assessment of inhaled bronchodilator or steroid therapy

机译:非麻醉大鼠梭曼蒸气的吸入毒性:吸入性支气管扩张药或类固醇疗法的初步评估

获取原文
获取原文并翻译 | 示例
           

摘要

Respiratory toxicity, injury and treatment following vapor inhalational exposure to the chemical warfare nerve agent (CWNA) soman (GD) were examined in non-anesthetized rats. This study exposed male Sprague-Dawley rats (250-300 g) to 520, 560, 600, 825 or 1410 mg × min/m3 of soman in a customized head-out inhalation system. Signs of CWNA-induced cholinergic crises were observed in all soman-exposed animals. The LCt50 of vaporized soman as determined by probit analysis was 593.1 mg × min/m3. All animals exposed to 825 and 1410 mg × min/m3 developed severe convulsions and died within 4-8 min post-exposure. Edema measured by wet/dry weight ratio of the left lung lobe increased in a dose-dependent manner in all soman-exposed animals. Bronchoalveolar lavage (BAL) fluid and blood acetylcholinesterase (AChE) activities were inhibited dose-dependently in soman-exposed groups at 24 h. A significant increase in total BAL protein was observed in soman-exposed animals at all doses. AChE activity was inhibited in lung and whole brain tissues in all soman-exposed animals. Histopathological analysis of the lungs of animals exposed to 600 mg × min/m3 of soman revealed prominent morphological changes including alveolar histiocytosis, hemorrhage and inflammation consisting of neutrophilic exudate. Exposure of animals to 600 mg × min/m3 of soman followed by treatment with two actuations for 10 s of Combivent (21 μg of ipratropium bromide and 120 μg of albuterol sulfate) and Symbicort (80 μg budesonide and 4.5 μg formoterol) by inhalation into a modified metered dose inhaler (MDI) 10 min post-exposure resulted in increased minute volume, but did not decrease mortality. These results indicate that inhalation exposure to soman vapor causes acute respiratory toxicity and injury in untreated, un-anesthetized rats and that inhalation treatment with Combivent or Symbicort did improve the respiratory outcomes, but did not influence lethality.
机译:在未麻醉的大鼠中检查了化学吸入神经毒剂(CWNA)梭曼(GD)的蒸气吸入后的呼吸毒性,伤害和治疗。这项研究在定制的抬头式吸入系统中将雄性Sprague-Dawley大鼠(250-300 g)暴露于520、560、600、825或1410 mg×min / m3梭曼。在所有接触人类的动物中均观察到了CWNA诱导的胆碱能危机的迹象。经概率分析确定汽化梭曼的LCt50为593.1 mg×min / m3。暴露于825和1410 mg×min / m3的所有动物均出现严重惊厥,并在暴露后4-8分钟内死亡。在所有人暴露的动物中,以左肺叶干/湿重量比测量的水肿以剂量依赖性方式增加。在24小时内,梭曼接触组的支气管肺泡灌洗(BAL)液和血液乙酰胆碱酯酶(AChE)活性受到剂量依赖性抑制。在所有剂量下,暴露于梭曼的动物中总BAL蛋白均显着增加。在所有暴露于人类的动物中,AChE活性在肺和整个脑组织中均受到抑制。对暴露于600 mg×min / m3 soman的动物的肺进行组织病理学分析,发现了明显的形态学变化,包括肺泡组织细胞增生,出血和由嗜中性白细胞渗出液组成的炎症。将动物暴露于600 mg×min / m3的梭曼中,然后两次吸入10 s Combivent(21μg异丙托溴铵和120μg硫酸沙丁胺醇)和Symbicort(80μg布地奈德和4.5μg福莫特罗)进行处理暴露后10分钟使用改良的定量吸入器(MDI)可以增加分钟体积,但不会降低死亡率。这些结果表明,吸入未暴露的梭曼蒸气会引起急性呼吸道毒性和伤害,并且未麻醉的大鼠使用Combivent或Symbicort进行吸入处理确实可以改善呼吸效果,但不会影响致死性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号